Paper19230643
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.
Reinhardt HC and 1 other. Curr Opin Cell Biol, 2009. Cited by 407 papers, by iCite.
Cite this record
ConductScience Library. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Papers, record 19230643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19230643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle | Major topic |
| DNA Damage | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Protein Kinases | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Animals | |
| Checkpoint Kinase 1 | |
| Checkpoint Kinase 2 | |
| Enzyme Activation | |
| Humans | |
| Multiprotein Complexes | |
| MAP-Kinase-Activated Kinase 2 |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ES015339 | NIEHS NIH HHS | United States | R01ES015339 | PubMed and NIH | NIH RePORTER |
| R01 ES015339 | NIEHS NIH HHS | United States | R01ES015339 | PubMed and NIH | NIH RePORTER |
| R01 GM060594 | NIGMS NIH HHS | United States | R01GM060594 | PubMed and NIH | NIH RePORTER |
| CA112967 | NCI NIH HHS | United States | U54CA112967 | PubMed and NIH | NIH RePORTER |
| P50 GM068762 | NIGMS NIH HHS | United States | P50GM068762 | PubMed and NIH | NIH RePORTER |
| GM68762 | NIGMS NIH HHS | United States | P50GM068762 | PubMed and NIH | NIH RePORTER |
| U54 CA112967 | NCI NIH HHS | United States | U54CA112967 | PubMed and NIH | NIH RePORTER |
| R21 CA109661 | NCI NIH HHS | United States | R21CA109661 | PubMed and NIH | NIH RePORTER |
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15549093 | Cell-cycle checkpoints and cancer. | Nature | 2004 | https://conductscience.org/library/papers/15549093 | PubMed |
| 2 | 17395714 | Molecular basis of MAPK-activated protein kinase 2:p38 assembly. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17395714 | PubMed |
| 3 | 18158901 | Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. | Mol Cell | 2007 | https://conductscience.org/library/papers/18158901 | PubMed |
| 4 | 16497931 | Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. | Science | 2006 | https://conductscience.org/library/papers/16497931 | PubMed |
| 5 | 9034337 | Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. | EMBO J | 1997 | https://conductscience.org/library/papers/9034337 | PubMed |
| 6 | 8642659 | Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. | J Virol | 1996 | https://conductscience.org/library/papers/8642659 | PubMed |
| 7 | 11085506 | Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. | Cancer Res | 2000 | https://conductscience.org/library/papers/11085506 | PubMed |
| 8 | 18594563 | ATR: an essential regulator of genome integrity. | Nat Rev Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18594563 | PubMed |
| 9 | 16141325 | A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16141325 | PubMed |
| 10 | 11511366 | Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. | Mol Cell | 2001 | https://conductscience.org/library/papers/11511366 | PubMed |
| 11 | 18560558 | Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. | PLoS One | 2008 | https://conductscience.org/library/papers/18560558 | PubMed |
| 12 | 17525332 | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | Science | 2007 | https://conductscience.org/library/papers/17525332 | PubMed |
| 13 | 10523629 | DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10523629 | PubMed |
| 14 | 12805407 | Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. | Mol Cancer Res | 2003 | https://conductscience.org/library/papers/12805407 | PubMed |
| 15 | 17486112 | Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. | Nat Cell Biol | 2007 | https://conductscience.org/library/papers/17486112 | PubMed |
| 16 | 18583988 | Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. | EMBO Rep | 2008 | https://conductscience.org/library/papers/18583988 | PubMed |
| 17 | 16456545 | Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. | EMBO J | 2006 | https://conductscience.org/library/papers/16456545 | PubMed |
| 18 | 15758953 | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | Nature | 2005 | https://conductscience.org/library/papers/15758953 | PubMed |
| 19 | 11751453 | 14-3-3 binding regulates catalytic activity of human Wee1 kinase. | Cell Growth Differ | 2001 | https://conductscience.org/library/papers/11751453 | PubMed |
| 20 | 15302851 | Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. | J Cell Biol | 2004 | https://conductscience.org/library/papers/15302851 | PubMed |
Cited by265
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 407 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42655879 | An Ancestral Mechanism of Calmodulin Binding to Cds1 Kinase Inhibits Catalytic Activity. | IUBMB Life | 2026 | https://conductscience.org/library/papers/42655879 | PubMed |
| 41989650 | Interaction of flavonoids with DNA: implications in cancer treatment. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41989650 | PubMed |
| 41463266 | In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463266 | PubMed |
| 41003242 | Unconventional binding of calmodulin to CHK2 kinase inhibits catalytic activity. | Biochem J | 2025 | https://conductscience.org/library/papers/41003242 | PubMed |
| 40699616 | Krüppel-like Factor 4-Deficient Cells Are Sensitive to Etoposide-Induced DNA Damage. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699616 | PubMed |
| 40619351 | Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review. | BMC Med | 2025 | https://conductscience.org/library/papers/40619351 | PubMed |
| 40613709 | Depletion of BRD9-mediated R-loop accumulation inhibits leukemia cell growth via transcription-replication conflict. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40613709 | PubMed |
| 40195731 | Dual Disruption of DNA Repair by a Novel CHK2 Inhibitor, ART-446, and Olaparib is a Promising Strategy for Triple-Negative Breast Cancer Therapy. | Biomol Ther (Seoul) | 2025 | https://conductscience.org/library/papers/40195731 | PubMed |
| 39769375 | Tumorigenesis Caused by Aberrant Expression of GANP, a Central Component in the Mammalian TREX-2 Complex-Lessons from Transcription-Coupled DNA Damages. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769375 | PubMed |
| 39273409 | From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273409 | PubMed |
| 39122719 | Cryo-EM structure of the CDK2-cyclin A-CDC25A complex. | Nat Commun | 2024 | https://conductscience.org/library/papers/39122719 | PubMed |
| 39080354 | REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity. | Leukemia | 2024 | https://conductscience.org/library/papers/39080354 | PubMed |
| 38963141 | Deciphering the molecular landscape of ionising radiation-induced eye damage with the help of genomic data mining. | Arh Hig Rada Toksikol | 2024 | https://conductscience.org/library/papers/38963141 | PubMed |
| 38868315 | Advances in synthetic lethality modalities for glioblastoma multiforme. | Open Med (Wars) | 2024 | https://conductscience.org/library/papers/38868315 | PubMed |
| 38798459 | Unraveling systemic responses to NQO1-activated IB-DNQ and Rucaparib single and dual agent therapy in triple-negative breast cancers. | bioRxiv | 2025 | https://conductscience.org/library/papers/38798459 | PubMed |
| 38740853 | Eugenol as a potential adjuvant therapy for gingival squamous cell carcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/38740853 | PubMed |
| 38596432 | The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities. | NAR Cancer | 2024 | https://conductscience.org/library/papers/38596432 | PubMed |
| 38124747 | Mouse models of diffuse large B cell lymphoma. | Front Immunol | 2023 | https://conductscience.org/library/papers/38124747 | PubMed |
| 37781317 | Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37781317 | PubMed |
| 37524790 | SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. | Nat Genet | 2023 | https://conductscience.org/library/papers/37524790 | PubMed |
Genes57
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19230643
GET https://conductscience.org/api/papers/v1/19230643/references?page=2